Boosting brainpower? From the medicalisation of cognition to the pharmaceuticalisation of routine mental life
Journal title SALUTE E SOCIETÀ
Author/s Catherine Coveney, Jonathan Gabe, Simon Williams
Publishing Year 2013 Issue 2012/Suppl. 2EN
Language English Pages 15 P. 151-165 File size 233 KB
DOI 10.3280/SES2012-SU2010EN
DOI is like a bar code for intellectual property: to have more infomation
click here
Below, you can see the article first page
If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits
FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.
Sociological engagement with debates around the promise, problems and prospects of pharmaceutical cognitive enhancment is still at an early stage. In this paper we attempt to explore how the prospect of cognitive enhancement can be understood using existing sociological concepts of medicalisation, biomedicalisation and pharmaceuticalisation. Drawing on two case studies, that of Mild Cognitive Impairment (MCI) and the use of modafinil to enhance alertness, we discuss the idea of enhancement medicine and the use of cognitive enhancers outside of medical authority. We suggest that whilst all three of the above concepts shed important light on these developments, overlapping and converging as they do in various ways, pharmaceuticalisation provides a more precise sociological term of reference. We end with some suggestions for a research agenda for tracing and tracking trends in pharmaceutical cognitive enhancement over time.
Keywords: Enhancement; Cognition; Biomedicalisation; pharmaceuticalisation; mental health
Catherine Coveney, Jonathan Gabe, Simon Williams, Boosting brainpower? From the medicalisation of cognition to the pharmaceuticalisation of routine mental life in "SALUTE E SOCIETÀ" Suppl. 2EN/2012, pp 151-165, DOI: 10.3280/SES2012-SU2010EN